.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Carpal tunnel release is highly effective, but surgeons continue to debate whether an endoscopic approach produces a better overall recovery than traditional open release. This randomized trial compared the two techniques across symptom severity, complications, pain, grip strength and return to work. Both procedures produced substantial improvement, and the major outcome measures were broadly comparable over follow-up. Endoscopic release offered some early advantages in pain and grip strength, but these differences narrowed over time. The trial therefore supports the view that both techniques are effective and that the choice should be driven by surgeon expertise, patient preference, anatomy and resource considerations rather than expectations of a dramatic long-term functional difference. The study also highlights an important issue in procedural comparisons: early recovery benefits can exist without a meaningful difference in ultimate outcome. For HCPs, the practical takeaway is to set realistic expectations. Endoscopic release may allow a somewhat quicker early recovery in some patients, but open release remains an effective standard approach. Shared decision-making should incorporate incision-related concerns, work demands, previous surgery and the local complication profile of the surgeon or centre.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Carpal tunnel release is highly effective, but surgeons continue to debate whether an endoscopic approach produces a better overall recovery than traditional open release. This randomized trial compared the two techniques across symptom severity, complications, pain, grip strength and return to work. Both procedures produced substantial improvement, and the major outcome measures were broadly comparable over follow-up. Endoscopic release offered some early advantages in pain and grip strength, but these differences narrowed over time. The trial therefore supports the view that both techniques are effective and that the choice should be driven by surgeon expertise, patient preference, anatomy and resource considerations rather than expectations of a dramatic long-term functional difference. The study also highlights an important issue in procedural comparisons: early recovery benefits can exist without a meaningful difference in ultimate outcome. For HCPs, the practical takeaway is to set realistic expectations. Endoscopic release may allow a somewhat quicker early recovery in some patients, but open release remains an effective standard approach. Shared decision-making should incorporate incision-related concerns, work demands, previous surgery and the local complication profile of the surgeon or centre.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
